|
LOC400657 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-15 |
| Normal-vs-Stage2 |
1.610770E-04 |
| Normal-vs-Stage3 |
5.08915132257926E-12 |
| Normal-vs-Stage4 |
1.64412927716739E-12 |
| Stage1-vs-Stage2 |
1.214140E-02 |
| Stage1-vs-Stage3 |
3.500200E-01 |
| Stage1-vs-Stage4 |
3.122700E-03 |
| Stage2-vs-Stage3 |
9.481600E-03 |
| Stage2-vs-Stage4 |
5.85290000000294E-05 |
| Stage3-vs-Stage4 |
6.537600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.79860000000454E-05 |
| Normal-vs-Asian |
2.35210000365527E-08 |
| Caucasian-vs-AfricanAmerican |
4.614800E-01 |
| Caucasian-vs-Asian |
2.234400E-01 |
| AfricanAmerican-vs-Asian |
9.099400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85520487860913E-11 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.729600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
3.84190457225486E-11 |
| Normal-vs-Age(61-80Yrs) |
1.85980009170805E-10 |
| Normal-vs-Age(81-100Yrs) |
2.792300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.936400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.006000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.735400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.422000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.090200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.288600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.73580000000429E-05 |
| Classical-VS-Follicular |
5.203800E-02 |
| Classical-VS-Other |
6.929400E-01 |
| Classical-VS-Normal |
1.62614366416847E-12 |
| Tall-VS-Follicular |
1.32490000004371E-06 |
| Tall-VS-Other |
2.184400E-01 |
| Tall-VS-Normal |
1.62614366416847E-12 |
| Follicular-VS-Other |
8.213200E-01 |
| Follicular-VS-Normal |
2.79789999946267E-07 |
| Other-VS-Normal |
1.541890E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11760045662379E-10 |
| Normal-vs-N1 |
1.22124532708767E-14 |
| N0-vs-N1 |
6.10839999999335E-05 |
|
|
